[Immunologic and pharmacological principles for the use of immunosuppressive drugs in autoimmune diseases].
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology; D002455:Cell Division / Q000187:drug effects; D006801:Humans; D007108:Immune Tolerance; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D007239:Infections / Q000139:chemically induced; D007249:Inflammation / Q000517:prevention & control; D009369:Neoplasms / Q000139:chemically induced; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D013997:Time Factors
D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D009588:Nitrogen Mustard Compounds
Immunologische und pharmakologische Grundlagen für die Anwendung immunosuppressive Medikamente bei Autoimmunkrankheiten.